Evidence map›Paper›PMID 11032806›Full record

ArticleThe EMBO journal2000

MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells.

T P Garrington, T Ishizuka, P J Papst, K Chayama, S Webb, T Yujiri, W Sun, S Sather, D M Russell, S B Gibson and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cell Signaling and Stress Responses.Cold Spring Harbor perspectives in biology · 2016
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Mitogen-activated protein kinase signalling and ERK1/2 bistability in asthma.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2011
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

T P GarringtonDepartment of Pharmacology and University of Colorado Cancer Center, University of Colorado Health Sciences Center, Denver, CO 80206, USA.
T Ishizuka
P J Papst
K Chayama
S Webb
T Yujiri
W Sun
S Sather
D M Russell
S B Gibson
G Keller
E W Gelfand
G L Johnson
University of Colorado Anschutz Medical Campus · US

Funding

RECEPTOR INTERACTION WITH GTP REGULATORY PROTEINSR37GM030324 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JOHNSON, GARY L. · 1999 to 2008
$3.7M
REGULATION OF SEQUENTIAL PROTEIN KINASE PATHWAYSR01DK037871 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JOHNSON, GARY L. · 1986 to 2011
$3.7M
REGULATORY PROTEINS OF ADENYLATE CYCLASER01GM030324 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JOHNSON, GARY L. · 1985 to 2012
$1.8M
MEKK2 KO DEFINES HEMATOPOIETIC CELL SIGNAL FUNCTIONK08CA085276 · NCI · UNIVERSITY OF COLORADO DENVER · PI GARRINGTON, TIMOTHY P · 2000 to 2004
$672k
NCI NIH HHS CA85276NCI NIH HHS K08 CA085276NIDDK NIH HHS DK37871NIDDK NIH HHS R01 DK037871NIGMS NIH HHS GM30324NIGMS NIH HHS R01 GM030324NIGMS NIH HHS R37 GM030324
6 · The paper itself

Abstract

Ligation of the high-affinity IgE receptor (FcepsilonRI) or of c-Kit stimulates cytokine production in mast cells. We show that MEK kinase 2 (MEKK2), a MAPK kinase kinase (MAP3K) that regulates the JNK and ERK5 pathways, is required for cytokine production in embryonic stem (ES) cell-derived mast cells (ESMC). Targeted disruption of the MEKK2 or MEKK1 gene was used to abolish expression of the respective kinases in ESMC. Transcription of specific cytokines in response to IgE or c-Kit ligand was markedly reduced in MEKK2(-/-) ESMC relative to wild-type ESMC. Cytokine production in MEKK1(-/-) ESMC was similar to that of wild-type ESMC, demonstrating the specificity of MEKK2 in signaling cytokine gene regulation. MEKK2(-/-) ESMC also lost receptor-mediated stimulation of JNK. In contrast, JNK activation in response to UV irradiation was normal, showing that MEKK2 is required for receptor signaling but not for cellular stress responses. MEKK2 is the first MAP3K shown to be required for mast cell tyrosine kinase receptor signaling controlling cytokine gene expression.

Indexed as

MAP Kinase Kinase Kinase 1MAP Kinase Signaling SystemAnimalsCell DifferentiationCell LineCytokinesEnzyme ActivationJNK Mitogen-Activated Protein KinasesMAP Kinase Kinase Kinase 2MAP Kinase Kinase KinasesMast CellsMiceMitogen-Activated Protein KinasesMutagenesis, Site-DirectedMutationp38 Mitogen-Activated Protein KinasesCytokinesJNK Mitogen-Activated Protein KinasesMap3k1 protein, mouseMap3k2 protein, mouseMAP Kinase Kinase Kinase 1MAP Kinase Kinase Kinase 2MAP Kinase Kinase KinasesMitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesProtein Serine-Threonine KinasesReceptors, IgERNA, MessengerStem Cell FactorTumor Necrosis Factor-alpha

Identifiers

PMID11032806
PMCPMC314024
OpenAlexW2106412710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.